In a 36-year-old female with a known small pituitary lesion previously treated with cabergoline, recent irregular heavy menses, night sweats, insomnia, mood changes, episodic tachycardia, near‑syncope, and a magnetic resonance imaging performed two years ago, should I obtain an immediate follow‑up pituitary magnetic resonance imaging with contrast, and which specific imaging protocol and baseline endocrine laboratory studies should be ordered before referral to endocrinology?

Immediate Pituitary MRI with Contrast is Recommended

Yes, you should order an immediate follow-up MRI of the pituitary with contrast given the 2-year imaging gap, new concerning symptoms suggesting possible hormonal dysfunction, and history of a pituitary lesion previously treated with cabergoline. This patient's constellation of symptoms—irregular heavy menses, night sweats, mood changes, episodic tachycardia, and near-syncope—raises concern for evolving pituitary pathology that requires urgent imaging before endocrinology evaluation 1.

Specific MRI Protocol to Order

Order: MRI Brain with and without IV contrast, dedicated pituitary protocol with thin-section imaging

The imaging should include 1:

• Pre-contrast sequences: T1-weighted and T2-weighted images
• Post-contrast sequences: T1-weighted thin-sliced images (2mm slice thickness)
• Post-contrast volumetric sequences: Spoiled gradient-echo 3D T1 sequences for increased sensitivity in detecting microadenomas
• Specify: Dedicated pituitary/sellar cuts with high-resolution, focused field-of-view imaging

This protocol represents the gold standard for pituitary imaging and increases conspicuity of small adenomas, which typically appear as hypoenhancing lesions 1. The ACR Appropriateness Criteria specifically endorses MRI with contrast as the imaging investigation of choice for suspected hormone-secreting adenomas 1.

Baseline Endocrine Laboratory Studies to Order Now

Comprehensive hormonal evaluation should be performed immediately, before the endocrinology referral 1:

Essential baseline labs:

• Morning (8 AM) cortisol and ACTH - to evaluate for secondary adrenal insufficiency, which could explain her near-syncope and dizziness 1
• TSH and free T4 - central hypothyroidism can cause irregular menses, mood changes, and fatigue 1
• Prolactin level - essential given prior cabergoline treatment; even "non-functioning" adenomas can have occult hyperprolactinemia 1, 2
• LH, FSH, and estradiol - given irregular menses, mood changes, and potential hypogonadism in a premenopausal female 1
• IGF-1 level - to rule out growth hormone excess that may not be clinically apparent 1
• Electrolytes - to assess for potential SIADH or other electrolyte disturbances 1

The prevalence of hypopituitarism in patients with pituitary adenomas ranges from 37-85%, with gonadotropin deficiency (36-96%) and central hypothyroidism (8-81%) being common 1. Routine endocrine evaluation of all anterior pituitary axes is recommended because deficits often exceed clinical suspicion 1.

Clinical Reasoning for Urgent Imaging

Several factors justify immediate imaging rather than waiting for endocrinology 1:

• Two-year imaging gap: Given the known pituitary lesion and prior treatment with cabergoline, a 2-year interval without surveillance imaging is excessive 1
• New hormonal symptoms: The constellation of irregular heavy menses, night sweats, mood changes suggests possible multiple pituitary hormone deficiencies 1
• Cardiovascular symptoms: Episodic tachycardia and near-syncope could indicate adrenal insufficiency or other hormonal crisis 1
• Prior cabergoline treatment: This suggests the lesion was likely a prolactinoma; these require ongoing monitoring even after treatment 3, 2

Important Caveats About Cabergoline History

The patient's prior cabergoline treatment raises several considerations 3:

• Cardiac surveillance needed: All patients on cabergoline require cardiovascular evaluation including echocardiography to assess for valvular disease, particularly if she was on doses >2mg/day or prolonged therapy 3
• Treatment discontinuation: The FDA label indicates that after maintaining normal prolactin for 6 months, cabergoline may be discontinued with periodic monitoring 3
• Tumor regrowth: Without ongoing surveillance, prolactinomas can regrow after cabergoline discontinuation 4, 2

Why Not Wait for Endocrinology

While endocrinology referral is appropriate, obtaining imaging and baseline labs now provides several advantages 1:

• Expedites specialist evaluation: Endocrinologists will need these studies regardless; having them completed accelerates diagnosis
• Identifies urgent pathology: Mass effect, apoplexy, or significant tumor growth may require neurosurgical consultation 1
• Guides replacement therapy: If severe adrenal insufficiency or hypothyroidism is identified, replacement should begin before other interventions to avoid precipitating adrenal crisis 1

Follow-up Considerations

Long-term radiologic, endocrinologic, and ophthalmologic surveillance monitoring is recommended for pituitary adenomas to evaluate for tumor recurrence or regrowth 1. The first radiologic study to evaluate extent of any changes should ideally be performed within 3 months of any intervention, though in this case immediate imaging is warranted given the symptom burden and imaging gap 1.

If visual symptoms develop or the tumor approaches the optic chiasm on imaging, formal ophthalmologic evaluation with visual field testing (Goldmann perimetry) and visual acuity assessment should be obtained 1.